Latest Conference Coverage

Randalyn Harreld, CRCST, CIS, CER, CHL, CSPDT, CASSPT, CLS, AAS, FHSPA, clinical education manager for Steelco Belimed

Sterile processing professionals face constant interruptions, cognitive overload, increasingly complex devices, and hundreds of IFUs. Randalyn Harreld, CRCST, FHSPA, explains why health care organizations must address the human factors behind SPD performance rather than expecting frontline professionals to simply absorb ever-increasing complexity.

HIV virus  (Adobe Stock 3483234 by Yang MingQi)

Long-acting HIV therapies promise greater convenience, but fewer doses alone may not solve adherence or access challenges. Lloyd Bibby and Pooja Goyal, MS(Pharm), discuss patient choice, weekly oral and injectable therapies, health system capacity, equitable access, and the real-world measures that will define success.

Dyan Troxell, MSN, RN, director of clinical education at HandCraft Linen Services; J.J. Odom, MBA, CHESP, CMIP, T-CHEST, university director of buildings and grounds for UConn Health and chair-elect of the AHE Board; and Jenna Rivers, MPH, CPH, CIC, manager of infection prevention and control at Moffitt Cancer Center in Tampa, Florida.

At AHE Exchange 2026, ICT spoke with experts representing commercial laundry services, EVS, and infection prevention about the systems behind a successful reusable linen program. They discuss linen quality, reject rates, unnecessary waste, frontline education, data, PAR levels, infection prevention oversight, and why strong relationships between health care facilities and their laundry providers matter.

Sadé L. Rolon, MBA, CMIP, CHESP, T-CHEST, T-CSCT, the regional director of operations for Sodexo’s Healthcare Division,  Julie Mangino, MD, infectious disease specialist at The Ohio State University Medical Center, Columbus, OH,  James “JJ” Odom, MBA, CHESP, CMIP, T-CHEST, the university director of buildings & grounds at UConn Health, Farmington, Connecticut,  Christopher Dugard, MS, director for the Division of Infection Control Devices in the Office of Surgical and Infection Control Devices, FDA/Center for Devices and Radiological Health.  and Elizabeth “Liz” Claverie, MS, (retired CAPT, 0-6) vice president, regulatory strategic liaison for Steris.  (Image credit: Author)

During an expert panel at Exchange26 on whole-room microbial reduction technologies, regulatory and health care leaders discussed the distinction between FDA and EPA oversight, what constitutes a medical device claim, the risks surrounding unauthorized or off-label claims, and why IP and EVS professionals should verify a device's regulatory status rather than relying solely on vendor presentations.

Donald Sipp, Jr, MBA, RESE, CHESP, CHTI-2, CMIP, PMP, and David Green  (Image credit: author)

“Cutting” waste shouldn’t mean cutting people. At AHE Exchange26, David Green and Donald Sipp explored how EVS departments can improve performance by strengthening workplace culture, empowering employees, eliminating inefficient processes, and understanding EVS’s critical role in patient throughput. One case study showed bed turnaround times falling from nearly 2 hours to less than an hour, but the larger lesson wasn't simply about speed. High-performing EVS operations begin with a strong foundation.

Association for Professionals in Infection Prevention and Epidemiology Annual Conference and Exposition (APIC 2026) held from June 15 to 17, 2026, in Nashville, Tennessee.  Emily Frost, MPH, CIC, LTC-CIP, infection preventionist (IP) at Providence Kodiak Island Medical Center in Kodiak, Alaska.

What happens when your hospital is located on an island, and supplies take weeks to arrive? At APIC2026, Emily Frost, MPH, CIC, LTC-CIP, of Providence Kodiak Island Medical Center, shared how a critical access hospital in Alaska uses innovation, collaboration, and hands-on problem-solving to meet infection prevention and regulatory standards despite significant logistical challenges.

Darien Woods, MPH, CIC; and Michael TeKippe, MD, PhD  (Adobe Stock)

Researchers at Advocate Children's Hospital used genomic sequencing, active surveillance, and targeted infection prevention interventions to investigate and control a NICU CLABSI outbreak. Findings presented at #APIC2026 showed the cluster was not caused by a single hypervirulent MSSA strain but highlighted opportunities to strengthen hand hygiene, line maintenance, and ongoing surveillance.